ECS delivers 450% PCP growth in Q3 revenue, targets UK and European giants as new frontiers for its homegrown cannabis

ECS delivers 450% PCP growth in Q3 revenue, targets UK and European giants as new frontiers for its homegrown cannabis

ByBlaise

ECS Botanics has had another incredibly productive quarter, producing revenue of over $2m in Q3. And with the European majors opening up, the vertically integrated company says it’s in a great position with harvesting currently underway. Benchmark Aussie medicinal cannabis play ECS Botanics (ASX:ECS) has delivered more than $2million in revenue for the third quarter, as demand…

Canngea attracted to ECS Botanics’ sustainably grown cannabis, inks deal

Canngea attracted to ECS Botanics’ sustainably grown cannabis, inks deal

ByBlaise

The company flagged additional revenue opportunities in the year ahead as it establishes traction as the leading B2B supplier in the Australian cannabis market as the supply agreement with Canngea finalised. Leading medicinal cannabis company ECS Botanics (ASX:ECS) continues to execute on a rapid growth trajectory, as it gains traction as the supplier of choice for a…